App Column 1 | App Column 2 |
---|---|
Data Portal |
Website |
API |
Data Transfer Tool |
Documentation |
Data Submission Portal |
Legacy Archive |
This integrated, multiplatform PanCancer Atlas study co-mapped and identified distinguishing molecular features of squamous cell carcinomas (SCCs) from five sites associated with smoking and/or human papillomavirus (HPV). SCCs harbor 3q, 5p and other recurrent chromosomal copy number alterations (CNAs), DNA mutations, and/or aberrant methylation of genes and microRNAs, that are correlated with expression of multi-gene programs linked to squamous cell stemness, epithelial-to-mesenchymal differentiation, growth, genomic integrity, oxidative damage, death, and inflammation. Low-CNA SCCs tended to be HPV(+) and display hypermethylation with repression of TET1 demethylase and FANCF, previously linked to predisposition to SCC, or harbor mutations affecting CASP8, RAS-MAPK pathways, chromatin modifiers, and immunoregulatory molecules. We uncovered hypomethylation of the alternative promoter that drives expression of the DNp63 oncogene and embedded miR944. Co-expression of immune checkpoint, T-regulatory, and Myeloid suppressor cells signatures may explain reduced efficacy of immune therapy. These findings support new possibilities for molecular classification and therapeutic approaches.
For assistance, please contact the GDC Help Desk: support@nci-gdc.datacommons.io.
Want to know more about how our data is organized?
NIH… Turning Discovery Into Health ®